Get your appointment reminders by text!
Text HEARTPLACE to 622622
or scan the QR CODE with your smart phone.
Shelley A. Hall, M.D., is the Director of Heart Transplant Services for HeartPlace.
Dr. Baron L. Hamman was born in Memphis, Tennessee and grew up in Madisonville, Kentucky where his father was a prominent thoracic surgeon.
Dr. Lal specializes in Interventional Cardiology, Nuclear Cardiology, and Cardiovascular Disease.
HeartPlace is the past, present, and future of cardiology in North Texas. Founded almost 50 years ago, HeartPlace is the oldest and largest cardiovascular group in North Texas. From its small beginning in Dallas, HeartPlace has grown to over 70 physicians throughout the Dallas-Fort Worth metroplex. HeartPlace has been an innovator in cardiovascular services, introducing to the North Texas area procedures such as coronary angiography, angioplasty, coronary stenting, and electrophysiology. This dedication to innovative techniques and procedures has guaranteed our patients the latest and most up-to-date cardiovascular services...
Adults aged 65 years and older who are physically active, not obese, have modest alcohol intake and do not smoke were more likely to have a lower risk for HF compared with adults who do not report these positive lifestyle factors, according to results of a new study. Source: Healio Read More Read More
The U.S. Food and Drug Administration has approved the VenaSeal closure system (VenaSeal system) to permanently treat varicose veins of the legs by sealing the affected superficial veins using an adhesive agent. Source: Medical News Today Read More Read More
Physician-researchers in the College of Medicine at the University of Cincinnati have developed a computerized decision support tool that uses a combination of patient information and characteristics to assist physicians and patients with decisions about blood thinning treatment to prevent strokes in individuals with atrial fibrillation.
The results of a landmark study published this month in Circulation, indicate that a novel medical device from Medtronic, Inc. called the IN.PACT Admiral drug-coated balloon (DCB) significantly outperformed standard balloon angioplasty in the treatment of symptomatic peripheral artery disease in the upper leg - specifically, the superficial femoral and proximal popliteal arteries. Source: Medical News Today Read More Read More
A man's likelihood of accumulating fat around his heart - an important indicator of heart disease risk - may be better determined if doctors consider his race and ethnicity, as well as where on his body he's building up excess fat, reveals an international evaluation led by the University of Pittsburgh Graduate School of Public Health. Source: MedicalNewsToday Read More Read More